M
Matinas BioPharma Holdings, Inc. (MTNB)
0.56
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.56
0.00 (0.00%)
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 3.78 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 3.78 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.36 | 0.30 | 7.0 | |
| Qarz/Aktivlar nisbati | 0.24 | 1.04 | 7.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 7.0 | |||
| KO‘RSATKICH | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 33K | 3M | 1M | N/A | N/A |
| Yalpi foyda | -748K | 2M | 155K | -972K | -613K |
| Operatsion daromad | -25M | -25M | -24M | -20M | -9M |
| Sof foyda | -23M | -21M | -23M | -24M | -17M |
| EBITDA | -24M | -24M | -23M | -19M | -9M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | N/A | 1.0 |
| Keyingi chorak | N/A | N/A | 1.0 |
| Joriy yil | N/A | N/A | 1.0 |
| Keyingi yil | N/A | -233.33 | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | 59.01 | N/A | N/A | 5.5 |
| Yil/Yil | 999 | 49.71 | N/A | N/A | 5.5 |
| 3 yil o‘rtacha | 3099.5 | -1.7 | -0.44 | -3.08 | 3.3 |
| 5 yil o‘rtacha | 1859.17 | -7.6 | 3.78 | -3.63 | 4.0 |
| O‘rtacha ball | 4.6 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Kompaniyaning naqd pul zahiralari $5.5M umumiy qarzdan $2.3M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $5.7M jami joriy majburiyatlardan $1.5M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.4) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi